GLP-1 Microdosing Programs (2026): Who Offers a Low-Dose Option

The compounded GLP-1 telehealth programs that advertise a microdosing (low-dose) option, Gala GLP-1, Enhance MD, telos rx, and WellMedr, how each one packages it, and what to confirm before you start.

By RangeYourselfUpdated August 10, 20264 programs ranked

Microdosing means taking a lower-than-standard GLP-1 dose. Only a few compounded telehealth programs advertise it as an option, and they package it differently. The four below are the ones in our registry that offer a microdosing or low-dose plan, listed alphabetically, not ranked by price. Note that the “all-in monthly” column shows each program’s standard entry tier; the microdosing plan is a separate, usually lower-priced option described program-by-program below and in the semaglutide/tirzepatide columns.

Who this list is for

People who want a lower-dose GLP-1 plan, to start gently, hold a maintenance dose, or manage cost and side effects, and want to know which programs actually offer one.

Ranked programs: 4 verified, prices monitored daily, last change detected August 10, 2026

GLP-1 Microdosing Programs (2026): Who Offers a Low-Dose Option, each figure read from the provider’s own pricing page and dated individually, latest check August 10, 2026
Provider	All-in monthly	Semaglutide	Tirzepatide	Compounded vs brand	Insurance accepted?	Last verified	Price source
Enhance MD $212/mointro: $112 first month on GLP-1 Core (semaglutide), then $212/mo See pricing →	$212/mointro: $112 first month on GLP-1 Core (semaglutide), then $212/mo	Compounded, 'GLP-1 Core' $212/mo bundled program ($112 first month), verified 2026-07-14. Price reflects the metabolic program, not GLP-1 alone.	Compounded, 'GLP-1 Advanced' $280/mo; combo 'GLP-1 Elite' $322/mo; microdosing tirzepatide $169/mo, all bundled-program prices, verified 2026-07-14.	Compounded	No	2026-07-14price checkedan automated check re-read it 2026-09-03	enhance.md ↗	See pricing →
Gala GLP-1 $149/mo See pricing →	$149/mo	Compounded, $149–$199/mo (verified 2026-07-14): $179/mo standard 'all doses', $199/mo on a 3-month plan, $149/mo microdosing. Confirm the exact rate in enrollment.	Compounded GLP-1/GIP, from $179/mo; microdosing GLP-1/GIP $149/mo (verified 2026-07-14). Confirm the exact rate in enrollment.	Compounded	No	2026-07-14price checkedan automated check re-read it 2026-09-03	galaglp1.com ↗	See pricing →
telos rx Not publicly listed See pricing →	Not publicly listed	Compounded, advertised 'first month low as $49'; ongoing recurring rate not published (funnel-gated), confirm at enrollment	Compounded, injectable advertised 'first month low as $99'; oral 'first month low as $49'; microdosed 'first month low as $69'; ongoing recurring rate not published, confirm at enrollment	Compounded	No	2026-07-17price checked	telosrx.com ↗	See pricing →
WellMedr Not publicly listed See pricing →	Not publicly listed	Compounded, injectable and oral offered; recurring rate not published on the public site (funnel-gated), confirm at enrollment	Compounded, injectable and oral offered; recurring rate not published (funnel-gated). Microdose blend plans containing tirzepatide (with NAD+/B12, or B12/methionine/inositol) are page-priced at $199/mo (verified 2026-08-10), confirm the exact plan at enrollment	Both	No	2026-08-10price checked	,	See pricing →

Why we ranked them this way

Gala GLP-1 advertises microdosing GLP-1/GIP as its own named plan, priced below its standard tier, of the three, it is the only one that sells microdosing as a standalone plan rather than inside a bundle or an intro offer, bundled into the monthly price with no separate membership fee (confirm the exact ongoing rate at enrollment; Gala’s own pages show a price range, not a single number).
Enhance MD lists a microdosing tirzepatide option, but inside its bundled “Metabolic Reset” program with NAD+ and coaching, so the price reflects the fuller program, not medication alone.
telos rx advertises a microdosed tirzepatide with a first-month intro rate; its ongoing recurring price is funnel-gated (pricePublic:false), so it appears here without an assertable number, confirm at enrollment.
WellMedr sells microdosing as flat $199/mo blend subscriptions, tirzepatide combined with NAD+ and B12 (“Energy & Focus+”) or with B12, methionine, and inositol (“LipoForce+”), both page-priced (verified 2026-08-10). Its standard-dose GLP-1 pricing is funnel-gated, so no standard rate appears here. One caveat we verify so you don’t have to: WellMedr’s own pages are inconsistent about FDA status, a site-wide footer correctly discloses its compounded medications are not FDA-approved, while its FAQ and microdosing page claim otherwise; the footer has it right, compounded GLP-1s are not FDA-approved, and its microdosing page’s “zero side effects” claim is WellMedr’s marketing, not a clinical fact.
Microdosing is not a standardized clinical protocol, and a lower dose can mean a smaller effect. Treat it as a deliberate choice to make with your prescriber, ask what dose you are actually getting and how it will be titrated, not just what it costs.

The picks in detail

Enhance MD

Best for: Shoppers who want GLP-1 inside a fuller metabolic/NAD+ coaching program rather than medication-only.

Watchout: The $212–$322/mo figures are the BUNDLED program price, verified first-party to include '4 Weeks of Medication', 'Ongoing Provider Care & Support', and 'Metabolic Lab Testing Every 6 Months', NOT the cost of the GLP-1 medication alone. A first-month discount applies (e.g. $112 first month on GLP-1 Core)..

Pricing: $212/mo all-in (medication included), semaglutide compounded, 'glp-1 core' $212/mo bundled program ($112 first month), verified 2026-07-14. price reflects the metabolic program, not glp-1 alone., tirzepatide compounded, 'glp-1 advanced' $280/mo; combo 'glp-1 elite' $322/mo; microdosing tirzepatide $169/mo, all bundled-program prices, verified 2026-07-14..

See Enhance MD pricing →

Gala GLP-1

Best for: All-50-state compounded GLP-1 shoppers comparing cash-pay options.

Watchout: Gala lists a range rather than one recurring price: $179/mo 'all doses' in the hero, $199/mo 'with a 3-month plan' in the FAQ, and $149/mo for microdosing, confirm the exact ongoing rate in enrollment..

Pricing: $149/mo all-in (medication included), semaglutide compounded, $149–$199/mo (verified 2026-07-14): $179/mo standard 'all doses', $199/mo on a 3-month plan, $149/mo microdosing. confirm the exact rate in enrollment., tirzepatide compounded glp-1/gip, from $179/mo; microdosing glp-1/gip $149/mo (verified 2026-07-14). confirm the exact rate in enrollment..

See Gala GLP-1 pricing →

telos rx

Best for: One integrated care team across GLP-1, hormones/longevity, sexual health, and recovery (peptide-led telehealth) rather than a single-indication weight-loss pure-play.

Watchout: telos publishes only 'first month low as' intro figures (semaglutide $49, tirzepatide $99, oral tirzepatide $49, microdosed tirzepatide $69); the ongoing monthly rate is not shown on the public site and is confirmed inside the intake flow, confirm the real recurring price at enrollment. State availability is not published, no dispensing pharmacy is named, and shipped compounded medication is non-refundable..

Pricing: No single defensible price, see the pricing notes, semaglutide compounded, advertised 'first month low as $49'; ongoing recurring rate not published (funnel-gated), confirm at enrollment, tirzepatide compounded, injectable advertised 'first month low as $99'; oral 'first month low as $49'; microdosed 'first month low as $69'; ongoing recurring rate not published, confirm at enrollment.

See telos rx pricing →

WellMedr

Best for: Microdose-GLP-1 blend plans (tirzepatide combined with NAD+ or B12/MIC in one $199/mo subscription) and flat-priced prescription NAD+ ($99/mo advertised, same price every dose).

Watchout: WellMedr's own pages contradict each other on FDA status: a site-wide footer correctly states its compounded medications 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality,' while its FAQ answers 'Are these medications FDA approved? Yes.' and its microdosing page calls them 'FDA-approved compounds' and claims 'ZERO side effects' for most members, claims we do not repeat as fact. No dispensing pharmacy is named, no 503A/503B status is stated, no state list is published, and the main GLP-1 recurring price is only shown inside the intake funnel, confirm the real price, the pharmacy, and your state's eligibility before paying..

Pricing: No single defensible price, see the pricing notes, semaglutide compounded, injectable and oral offered; recurring rate not published on the public site (funnel-gated), confirm at enrollment, tirzepatide compounded, injectable and oral offered; recurring rate not published (funnel-gated). microdose blend plans containing tirzepatide (with nad+/b12, or b12/methionine/inositol) are page-priced at $199/mo (verified 2026-08-10), confirm the exact plan at enrollment.

See WellMedr pricing →

Frequently asked questions

What is GLP-1 microdosing?

Microdosing refers to using a lower-than-standard dose of a GLP-1 medication, often to ease into treatment, minimize side effects, or hold a maintenance dose after reaching a goal. It is a dosing choice, not a different drug, and it is not a formally standardized protocol; the right dose is a clinical decision for you and your prescriber.

Which telehealth programs offer a microdosing option?

In our registry, four compounded programs advertise a microdosing or low-dose plan: Gala GLP-1 (microdosing GLP-1/GIP as its own plan), Enhance MD (microdosing tirzepatide inside its bundled Metabolic Reset program), telos rx (a microdosed tirzepatide with a first-month intro rate, ongoing price confirmed at enrollment), and WellMedr (flat $199/mo microdose blend subscriptions combining tirzepatide with NAD+/B12 or B12/MIC). All four are compounded and not FDA-approved.

Does a lower GLP-1 dose still work?

A lower dose can produce a smaller effect than a standard therapeutic dose, per FDA prescribing information for approved GLP-1 medications, doses are titrated up to a target for a reason. Microdosing can be appropriate for tolerability or maintenance, but it is not a guaranteed shortcut to the same results. Discuss the trade-off with a clinician rather than choosing a dose by price.

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Each price carries its own verification date; the most recent on this page is August 10, 2026.